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Blood Vessels
Aortic Calcification Is Associated With Aortic Stiffness and
Isolated Systolic Hypertension in Healthy Individuals
Carmel M. McEniery, Barry J. McDonnell, Alvin So, Sri Aitken, Charlotte E. Bolton,
Margaret Munnery, Stacey S. Hickson, Yasmin, Kaisa M. Maki-Petaja, John R. Cockcroft,
Adrian K. Dixon, Ian B. Wilkinson; on behalf of the Anglo-Cardiff Collaboration Trial Investigators
Abstract—Arterial stiffening is an independent predictor of mortality and underlies the development of isolated systolic
hypertension (ISH). A number of factors regulate stiffness, but arterial calcification is also likely to be important. We
tested the hypotheses that aortic calcification is associated with aortic stiffness in healthy individuals and that patients
with ISH exhibit exaggerated aortic calcification compared with controls. A total of 193 healthy, medication-free
subjects (mean ageSD: 668 years) were recruited from the community, together with 15 patients with resistant ISH.
Aortic pulse wave velocity (PWV) was measured noninvasively, and aortic calcium content was quantified from
high-resolution, thoraco-lumbar computed tomography images using a volume scoring method. In healthy volunteers,
calcification was positively and significantly associated with aortic PWV (r0.6; P0.0001) but was not related to
augmentation index or brachial PWV. Calcification was significantly higher in treatment-resistant and healthy subjects
with ISH compared with controls (mean [interquartile range]: 1.92 [1.14 to 3.66], 0.84 [0.35 to 1.75], and 0.19 [0.1 to
0.78] cm3, respectively; P0.0001 for both). In a multiple regression model, aortic calcium was independently
associated with aortic PWV along with age, mean arterial pressure, heart rate, and estimated glomerular filtration rate
(R20.51; P0.0001). Only age, calcium phosphate product, and aortic PWV were independently associated with
calcification. These data suggest that calcification may be important in the process of aortic stiffening and the
development of ISH. Calcification may underlie treatment resistance in ISH, and anticalcification strategies may present
a novel therapy. (Hypertension. 2009;53:524-531.)
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In almost all societies, there is progressive stiffening of thelarge elastic arteries with age, resulting in a widening of
pulse pressure.1,2 Ultimately, this leads to the development of
isolated systolic hypertension (ISH), which is now the most
common form of hypertension in the United States and
United Kingdom, affecting approximately half of those aged
60 years.3 A widened pulse pressure, particularly in the
central arteries, leads to left ventricular hypertrophy and
increases the risk of stroke and myocardial infarction. Arterial
stiffening, per se, is also an important determinant of cardio-
vascular risk. Indeed, aortic pulse wave velocity (aPWV), the
current “gold-standard” measure of stiffness, predicts future
cardiovascular events in a variety of populations, including
unselected older adults, diabetics, and hypertensives, inde-
pendent of blood pressure.4
The precise mechanisms responsible for arterial stiffening
are incompletely understood but are thought primarily to
involve structural changes within the media, such as fatigue
fracture of elastin and deposition of collagen.5 An emerging
additional mechanism is arterial calcification.6 This may
occur in the intima, in conjunction with atherosclerotic
plaques, or in the media as arteriosclerosis. Although there
is an association between the 2 processes, they are patho-
logically distinct.7,8 Moreover, there is only a modest
correlation between atherosclerotic burden and aortic stiff-
ness.9 In animals, drug-induced vascular calcification leads
to aortic stiffening and the development of an ISH pheno-
type.10,11 In humans, ageing is associated with aortic
stiffening2 and medial calcification.12,13 Aortic calcifica-
tion is associated with left ventricular hypertrophy14 and
increased cardiovascular risk,15,16 and calcification is more
common in individuals with hypertension, diabetes melli-
tus, or renal failure.17,18 Interestingly, several studies have
reported a positive association between arterial calcifica-
tion and aPWV in subjects with chronic kidney disease
(CKD).19 –21 However, the relationship between arterial
calcification and aortic stiffness in the general population
remains unclear.
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We hypothesized that aPWV is independently related to
the degree of aortic calcification in healthy individuals and
that subjects with ISH, as a model of exaggerated aortic
stiffening, would have more extensive aortic calcification
than normotensive individuals. The aim of the present study
was to test this hypothesis in a community-based cohort of
unselected healthy subjects, without manifest cardiovascular
disease, and a cohort of treatment-resistant systolic hyperten-
sives, as a model of extreme arterial stiffening, using 16-
section computed tomography (CT) for accurate quantifica-
tion of aortic calcification.
Methods
Subjects
A total of 200 healthy subjects were recruited from the Anglo Cardiff
Collaborative Trial, an ongoing, community-based investigation into
the factors influencing arterial stiffness.2 Individuals were selected at
random from local general practice lists by letter of invitation (the
overall response rate was 85%). Subjects with diabetes mellitus,
hypercholesterolemia (self-reported or total cholesterol 6.5 mmol/
L), renal disease (defined as a clinical history, creatinine
150 mol/L, or an active urinary sediment), a history of cardio-
vascular disease (defined as a clinical history or evidence on
examination), known inflammatory conditions, malignancy, or a
recent history of infection were excluded from the present analyses,
as were subjects receiving any medication. In addition, 15 subjects
with treatment-resistant ISH were recruited from the hypertension
clinics at Addenbrooke’s Hospital. This was defined as a docu-
mented history of ISH and failure to achieve the current British
Hypertension Society target of140/85 mm Hg despite therapy with
3 antihypertensive drugs, including a thiazide diuretic, calcium
channel antagonist, and renin-angiotensin blocker. Approval was
obtained from the Local Research Ethics Committee, and written
informed consent was obtained from each participant.
Hemodynamics
Seated peripheral blood pressure was recorded in the brachial artery
using a validated oscillometric technique (HEM-705CP; Omron
Corporation). Radial artery waveforms were then recorded with a
high-fidelity micromanometer (SPC-301; Millar Instruments) from
the wrist of the same arm. Pulse wave analysis (SphygmoCor; AtCor
Medical) was then used to generate a corresponding central (ascend-
ing aortic) waveform using a generalized transfer function,22 which
has been prospectively validated for the assessment of ascending
aortic blood pressure.23,24 Augmentation index (AIx), a composite
measure of wave reflection; the height of the first systolic peak or
shoulder; wave travel time, time to the inflection point of the central
waveform; and heart rate were determined using the integral soft-
ware. Reflection time was defined as wave travel time divided by 2,
and reflection distance was estimated as aPWV multiplied by
reflection time.25 Mean arterial pressure (MAP) was calculated from
integration of the radial artery waveform. The aPWV was measured
using the same device by sequentially recording ECG-gated carotid
and femoral artery waveforms26 and brachial pulse wave velocity
(bPWV) from carotid and radial arteries.26 All of the measurements
were made in duplicate, and mean values were used in the
subsequent analysis.
CT Imaging
The entire aorta was visualized by obtaining 1.5-mm-thick slices
through the thorax, abdomen, and pelvis with unenhanced helical CT
(16-slice Siemens Medical Solutions system, Forchheim; total dose:
8 mSv). Analysis was conducted offline using a Leonardo work-
station with Syngo software. The degree of calcification was deter-
mined at 3 sites: the ascending aorta (valve to left subclavian);
descending thoracic aorta (left subclavian to diaphragm); and within
a defined section of abdominal aorta. Calcium quantification at the
first 2 sites was subjectively assessed by 2 trained observers who
graded calcification as no calcium present, flecks, moderate, or
confluent.27 This approach, which has been widely used,19,20,28 was
adopted because of the substantial curvature of the aorta in the
thorax, movement with respiration, and sparse amounts of calcium,
mainly as flecks, which are not well registered by the automated
software. In the abdominal aorta, an objective volume scoring
method included in the system software was used. The number of
voxels 130 HU within the wall of the aorta was determined along
a 5-cm segment just proximal to the bifurcation, which gave a score
in cubic centimeters (Figure 1). This is a validated and accurate
technique that compares favorably with electron beam CT,29,30 and
we have shown previously that this technique has excellent within-
and between-observer repeatability.31
Protocol
Height and weight were assessed. After 5 minutes seated rest, blood
pressure and radial artery waveforms were recorded. Subjects then
rested supine for 15 minutes, after which brachial blood pressure,
aPWV, and bPWV were recorded. Twenty mL of blood were drawn
from the antecubital fossa into plain tubes. The samples were
centrifuged at 4°C (4000 rpm for 20 minutes) and the serum
separated and stored at 80°C for subsequent analysis. Electrolytes,
cholesterol, triglycerides, glucose, C-reactive protein (CRP), and
parathyroid hormone were determined using standard methodology
in an accredited laboratory. Estimated glomerular filtration rate
(eGFR) was determined using the modified Modification of Diet in
Renal Disease formula. Subjects then underwent CT.
Data Analysis
Data were analyzed using SPSS software (version 15.0). When the
distribution of variables was significantly skewed (creatinine, eGFR,
CRP, parathyroid hormone, aPWV, and abdominal calcium score),
natural logarithmic transformations were applied before analysis.
Comparisons between groups were made using Student’s t tests or
ANOVA with Bonferroni corrections. Stepwise multiple linear
regression was performed to investigate the independent predictors
of aPWV and calcification. Variables entered into the model were
chosen if significantly associated in simple correlation analyses and
those variables known or previously associated with the dependent
variable from published observations. Values represent meansSDs
or medians (interquartile range), and a P value of 0.05 was
considered significant.
Results
Healthy Volunteers
Of the 200 healthy subjects recruited, data from 193
individuals were available for analysis (7 were excluded
Figure 1. A section through the abdomen illustrating calcifica-
tion within the aorta (white).
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because of the presence of atrial fibrillation, malignancy
on imaging, or the inability to complete the CT protocol).
The mean age of the cohort was 66 years (range: 51 to 92
years). There was a roughly equal gender distribution, and
21 subjects were current cigarette smokers and 75 were
ex-smokers. Based on seated blood pressure readings, 114
subjects were classified as normotensive (140/90 mm Hg), 61
met the criteria for ISH (140 and 90 mm Hg), and 18
had mixed systolic/diastolic hypertension (140 and
90 mm Hg). The demographics of the whole healthy
cohort (ie, normotensive subjects and untreated systolic
and mixed hypertensives) are presented in Table 1, and
detailed supine hemodynamic and imaging data are pre-
sented in Table 2.
There was a significant correlation between abdominal
aortic calcification score with that in the ascending (r0.3;
P0.001) and descending (r0.6; P0.001) thoracic aorta.
Calcification at all 3 of the sites was positively correlated
with aPWV, but the strongest correlation was with abdominal
calcium score (r0.4; P0.001), followed by descending
thoracic (r0.4; P0.001) and then ascending aorta (r0.2;
P0.008). Division of the cohort into quartiles of abdominal
calcification score suggested a dose-response relationship
with aPWV, which persisted even after adjusting for age and
MAP (P0.014; Figure 2). Neither bPWV (r0.1; P0.2)
nor AIx (r0.1; P0.5) was significantly related to cal-
cium score at any site. However, peripheral pulse pressure
was positively correlated with abdominal (r0.3; P0.001),
descending (r0.2; P0.003) and ascending (r0.2;
P0.04) thoracic calcium scores, and this remained signifi-
cant after adjustment for age, MAP, gender, smoking, and
height. Central pulse pressure was also correlated with
calcium score in the descending and abdominal aorta sites,
but to a lesser degree, and this was not significant after
adjustment.
The aPWV was also positively correlated with age, male
gender, weight, cigarette smoking, MAP, heart rate, serum
creatinine, and CRP and inversely with eGFR. Therefore,
stepwise multiple regression was used to determine the
independent predictors of aPWV. Abdominal calcium score
was used for the models, because it had the strongest bivariate
correlation with aPWV. In a simple model, abdominal aortic
calcium score alone explained 17% of the variance in
stiffness (Table 3, model 1). The addition of age, MAP, and
gender improved the R2 to 41%, and calcification remained
positively associated with aPWV (Table 3, model 2). Finally,
all of the univariate correlates of aPWV (but eGFR rather
than creatinine), together with height, total cholesterol, tri-
glycerides. and glucose, were included in a stepwise model.
This increased the R2 to 51%, but only age, MAP, eGFR,
heart rate, and aortic calcium score remained independent
predictors of aPWV (Table 3, model 3). Substitution with
ascending or descending thoracic calcium score reduced the
Table 1. Characteristics of the Healthy Subjects (n193)
Parameter Value
Age, y 668
Gender, male/female 99/94
Height, m 1.660.09
Weight, kg 7514
Seated SBP, mm Hg 14019
Seated DBP, mm Hg 8311
Heart rate, bpm 7413
Total cholesterol, mmol/L 5.31.1
Triglycerides, mmol/L 1.71.0
Glucose, mmol/L 5.20.8
Creatinine, mol/L 72 (60 to 85)
eGFR, mL/min per 1.73 m2 83 (63 to 121)
CRP, mg/L 2.28 (1.00 to 4.03)
Calcium, mmol/L 2.20.1
Phosphate, mmol/L 1.10.2
PTH, pmol/mL 2.97 (2.23 to 4.18)
Data are meansSDs or medians (interquartile range). SBP indicates
systolic blood pressure; DBP, diastolic blood pressure; PTH, parathyroid
hormone.
Table 2. Hemodynamic and Imaging Data From the Healthy
Subjects (n193)
Parameter Value
Supine SBP, mm Hg 13421
Supine DBP, mm Hg 7810
Supine MAP, mm Hg 9813
Heart rate, bpm 7413
Central supine SBP, mm Hg 12618
Central supine DBP, mm Hg 7910
AIx, % 319
aPWV, m/s 9.1 (7.9 to 10.7)
bPWV, m/s 8.6 (7.8 to 9.6)
Ascending aortic calcification, AU 0.220.56
Descending aortic calcification, AU 0.810.83
Abdominal aortic calcification, cm3 0.53 (0.04 to 1.65)
Data are meansSDs or medians (interquartile range). SBP indicates
systolic blood pressure; DBP, diastolic blood pressure; AU, arbitrary units.
Figure 2. Median aPWV as a function of quartiles of abdominal
aortic calcium score for all of the healthy subjects. aPWV has
been adjusted for age and MAP. Bars represent the 95% confi-
dence of the distribution (n193); P0.014 ANOVA.
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R2 of the models, and when all 3 of the calcium scores were
included, only abdominal calcification remained indepen-
dently associated with aPWV. Stratifying the analysis by
gender or substituting individual lipid subfractions did not
alter the associations (data not shown). Rerunning the models
for just the normotensive or untreated hypertensive healthy
subjects slightly reduced the R2 values, as might be expected,
but did not meaningfully alter any of the associations or the
strength of the relationship with vascular calcification.
Aortic calcification was positively associated with age,
male gender, serum creatinine, glucose, and aPWV and
inversely with eGFR. However, there was no significant
relationship with the calcium phosphate product (or concen-
trations of individual ions), serum parathyroid hormone, or
CRP levels. Multivariate analysis revealed that only age,
calcium phosphate product, and aPWV were independently
associated with aortic calcification (Table 4).
ISH and Aortic Calcification
To test the hypothesis that ISH is associated with exaggerated
aortic calcification, 2 subsets of healthy subjects were iden-
tified: those who were normotensive (n114) and those with
a confirmed diagnosis of ISH (n61), defined as a seated
systolic blood pressure 140 and diastolic 90 mm Hg on 3
occasions. An additional 15 individuals with treatment-resis-
tant ISH were studied; other than taking a thiazide diuretic,
angiotensin-converting enzyme inhibitor, and a calcium chan-
nel antagonist, 6 subjects were also receiving a -blocker, 2
an -blocker, and 1 spironolactone. The characteristics and
hemodynamic data for the 3 groups are presented in Table 5.
As expected, healthy subjects with ISH had a higher
aPWV, even after adjustment for MAP, than healthy normo-
tensives, but there was no difference in AIx. Reflection
distance and the height of the first systolic peak or shoulder
were increased in those with ISH, and reflection time was
reduced. They also had more extensive abdominal and
descending thoracic aortic calcification than controls. Both of
these differences were exaggerated in the resistant hyperten-
sives (Figure 3). The difference in abdominal aortic calcifi-
cation persisted after correcting for age or age2, gender,
MAP, smoking status, and creatinine (data not shown). There
was no difference in biochemical parameters other than
serum creatinine between the groups.
Discussion
Aortic stiffness is an important, independent predictor of
future cardiovascular risk in unselected older individuals.
However, the mechanisms underlying aortic stiffening are
incompletely understood. The aim of this study was to
explore the relationship between aortic stiffness and calcifi-
cation in healthy subjects using quantitative, high-resolution
CT imaging and aPWV, the current gold-standard measure of
arterial stiffness. The main novel findings were that calcifi-
cation in all regions of the aorta was positively correlated
with aPWV and that this relationship remained significant
after controlling for potential confounding influences. Aortic
calcification was also related to peripheral but not to central
pulse pressure or indices of wave reflection. Finally, we
demonstrated that ISH is associated with increased calcium
deposition in the aorta and that this is most marked in
individuals who are resistant to antihypertensive therapy.
Calcification of the large arteries in humans is well
recognized, particularly with ageing,12,13,32,33 CKD,16 and
diabetes mellitus.34 The impact of calcification on systemic
hemodynamics and aortic stiffness has largely been explored
in subjects with CKD. However, the majority of these studies
have only assessed calcification in one particular aortic
segment or used subjective measures of calcification based on
plain radiographs and/or ultrasound. Guerin et al19 reported a
positive association between a composite ultrasound-based
calcium score (abdominal aorta, ilio-femorals, legs, and
common carotid arteries) and aPWV in hemodialysis patients.
They went on to show that the presence of intimal and medial
calcification, in such patients, independently predicts mortal-
ity and morbidity.16 Using CT, 2 other groups have demon-
strated a correlation between aPWV and abdominal calcium
score in patients with CKD.21,35 Interestingly, Raggi et al20
reported that the abdominal but not the thoracic calcium score
was independently related to aortic stiffness in hemodialysis
patients. However, abdominal calcification was assessed by
Table 3. Multivariate Models for aPWV
Variable
Regression
CoefficientSE 
R 2
Change P
Model 1 (R 20.17;
P0.001)
Ln aortic calcification,
cm3
0.070.01 0.41 0.001
Model 2 (R 20.41;
P0.001)
Age, MAP, gender 0.37 0.001
Ln aortic calcification,
cm3
0.310.12 0.20 0.04 0.008
Model 3 (R 20.51;
P0.001)
MAP, mm Hg 0.080.01 0.40 0.22 0.001
Age, y 0.010.03 0.32 0.18 0.001
Heart rate, bpm 0.010.01 0.30 0.07 0.001
Ln aortic calcification,
cm3
0.010.01 0.15 0.03 0.03
Ln eGFR, mL/min per
1.73 m2
0.080.04 0.14 0.01 0.04
Excluded were height, weight, cholesterol, triglycerides, glucose, smoking,
gender, and ln CRP. aPWV was log transformed for this analysis. Ln indicates
log normal.
Table 4. Multivariate Model for Abdominal Aortic Calcification
Variable
(R 20.37, P0.001) Regression CoefficientSE  P
Age, y 0.080.02 0.46 0.001
Ln aPWV 1.530.57 0.28 0.008
Calcium phosphate product 0.790.36 0.22 0.03
Calcium score was log transformed for the analysis, as was the aPWV.
Excluded variables were height, weight, gender, cholesterol, triglycerides,
glucose, ln eGFR, ln CRP, ln parathyroid hormone, and smoking (all P0.2). Ln
indicates log normal.
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plain radiography, whereas thoracic deposition was quanti-
fied by electron beam CT. Sigrist et al36 demonstrated a
positive association between changes in arterial calcification
and aPWV in subjects with CKD over a 2-year period,
suggesting a potential causal relationship. However, they
assessed calcium deposition in the superficial femoral artery
rather than in the aorta. In healthy subjects, one small study
has reported a relationship between brachial-ankle pulse
wave velocity and the length of calcified abdominal aorta on
plain radiographs in Japanese subjects, but data on aPWV
were not available.37 Hypertension has been associated with
increased calcification and faster progression of calcifica-
tion.17,18 However, no data concerning calcification and ISH,
which can be considered primarily as a disease of arterial
stiffening, are available.
We determined aortic calcification at 3 distinct anatomic
locations (ascending, descending, and abdominal) using
unenhanced CT. This modality allows direct quantification
of vascular calcium load and is at least (if not more) as
accurate as electron beam CT.29 In the healthy subjects,
aPWV was positively correlated with calcification at all 3
of the aortic sites. As expected, aPWV was also related to
a number of other variables, including age, MAP, male
gender, cigarette smoking, and heart rate.2,5 After adjust-
ment for these and other potential factors influencing
arterial stiffness, aortic calcium content remained indepen-
dently correlated with aortic stiffness. In contrast, there
was no relationship between calcification and bPWV or
AIx, an index of wave reflection. This suggests that aortic
calcification is principally associated with localized stiff-
ening of the aorta rather than with systemic changes in
more peripheral vessels, or altered wave reflections, which
is perhaps unsurprising given the variability with which
arteries calcify and vessels stiffen.38
The lack of association between wave reflection and
calcification may seem surprising. However, we have dem-
Figure 3. A box-and-whisker plot of abdominal aortic calcium
score in normotensive and hypertensive individuals. Error bars
encompass all of the data, the line represents the median, and
the box the interquartile range. P0.0001 for trend.
Table 5. Characteristics of the Normotensive and ISH Subjects
Parameter Healthy (n114) ISH (n61) Resistant ISH (n15) P
Age, y 658 688* 748* 0.001
Gender, male/female 58/56 30/31 6/9 0.7
BMI, kg/m2 26.54.7 27.84.6 26.83.6 0.2
Smoker, n 12 7 0 0.4
Seated SBP, mm Hg 12812 15411 15616
Seated DBP, mm Hg 799 858 809
Heart rate, bpm 7212 7612 7214 0.1
Supine MAP, mm Hg 929 1039* 10611* 0.001
AIx, % 3110 319 346 0.5
P1, mm Hg 10310 11810* 11912* 0.001
Reflection distance, mm 594140 713181* 754197* 0.001
Reflection time, ms 687 655* 665 0.025
aPWV, m/s 8.4 (7.4 to 9.7) 10.6 (8.7 to 12.2)* 10.8 (10.0 to 14.0)* 0.001
Adjusted aPWV, m/s† 8.8 (7.8 to 10.2) 9.5 (7.8 to 11.5)* 10.7 (8.9 to 14.7)* 0.001
AA calcium, AU 0.220.58 0.210.52 0.330.50 0.8
DA calcium, AU 0.560.78 0.970.88* 1.670.71* 0.001
Abdo calcium, cm3 0.19 (0.10 to 0.78) 0.84 (0.35 to 1.75)* 1.92 (1.14 to 3.66)* 0.001
Creatinine, mol/L 70 (51 to 81) 76 (61 to 96) 84 (69 to 71) 0.06
eGFR, mL/min per 1.73 m2 84 (66 to 128) 83 (52 to 118) 78 (60 to 87) 0.07
Data are meansSDs or medians (interquartile range). BMI indicates body mass index; SBP, systolic blood pressure; DBP, diastolic
blood pressure; P1, height of first systolic peak; AA, ascending aortic; DA, descending aortic; Abdo, abdominal aortic. Overall
differences among the 3 groups are indicated in the final column (ANOVA).
*Significant differences on posthoc testing (Bonferroni) between normotensive and healthy ISH subjects or between normotensive
and resistant ISH subjects are indicated in the respective columns.
†Data are adjusted for MAP.
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onstrated previously that AIx changes little with age after the
6th decade, despite large changes in aPWV.2 One potential
explanation for the current observations is that calcification
leads to a distal shift in the apparent site of wave reflection.
This theory is supported by the longer reflection distance that
we observed in subjects with ISH. As such, the faster speed
of the reflected wave resulting from the increase in aPWV
would be offset by a greater path length, and the net effect
would be no change in AIx. Because central systolic pressure
is much more dependent on wave reflection than brachial
systolic pressure, this would also explain why calcification
was only associated with brachial and not aortic pulse
pressure. The reasons for the change in reflection distance
were not explored but may be a function of preferential
stiffening of the elastic arteries, resulting in better impedance
matching with the inherently stiffer muscular vessels of the
lower limbs.
Although often considered as uniform, the structure and
biophysical properties of the aorta change considerably along
its length, the abdominal portion being more muscular and
less elastic. As such, the pathological processes underlying
arterial stiffening may vary from one location to another. The
aPWV was most strongly correlated with calcification in the
abdominal aorta, which is consistent with the results of Raggi
et al20 in hemodialysis patients. This suggests that deposi-
tion of calcium in the abdominal aorta has a greater
influence on average aortic stiffness than calcification at
other locations. Given that the carotid-diaphragm and
diaphragm-femoral segments of the overall carotid-femoral
pathway are roughly equal in size, calcification appears to
have a greater functional impact on biomechanical prop-
erties of the abdominal aorta compared with the thoracic
portion. Nevertheless, it remains unclear as to which
section of the aorta stiffens most with age39,40 or the
development of ISH, and greater evidence of causality will
require regional measurement of aPWV and calcification
in the same patients over time.
Among unselected, otherwise healthy individuals, the ISH
phenotype was associated with increased aortic stiffness and
a greater aortic calcification, extending our previous obser-
vations.41 Both of these differences persisted after adjustment
for confounding variables, including MAP, and were much
more pronounced in a separate cohort of treatment-resistant
subjects with ISH. This suggests that aortic calcification may
play an important role in the development of ISH in humans,
as is the case in animal models of vascular calcification.11
Moreover, aortic calcification leading to exaggerated aortic
stiffening may explain why some individuals with ISH are
resistant to antihypertensive drugs, which largely lower blood
pressure by peripheral vasodilatation rather than a direct
effect on large arteries. Moreover, in CKD, aPWV is an
important determinant of the response to antihypertensive
therapy, which, in turn, predicts outcome,42 suggesting that
attenuation of aortic stiffening in ISH may be a valuable
additional therapeutic target.
A number of risk factors for arterial calcification have been
identified, including age, hypertension, hypercholesterol-
emia, cigarette smoking, and diabetes mellitus.32,33,43 Among
CKD patients the duration of dialysis, serum phosphate, and
inflammatory markers also seem important.16,19,44 However,
the majority of investigators did not use quantitative methods
to assess calcification and frequently included patients with
manifest cardiovascular disease. Moreover, other than age,
many of the other reported associations are relatively modest
and vary between gender and study. The only parameters
independently related to aortic calcification in the current
study, other than aPWV, were age and calcium phosphate
product. This may reflect the a priori exclusion of subjects
with manifest atherosclerosis, diabetes mellitus, CKD, and
those receiving cardiovascular medication. Nevertheless, the
multiple regression model in the present study only explained
40% of the variance in calcification, suggesting that addi-
tional factors are involved.
Limitations of the Present Study
The present study design was cross-sectional, and, therefore,
it is difficult to determine whether calcification causes arterial
stiffening. One counterargument is that aortic stiffening,
perhaps by virtue of degeneration of elastin fibers, which are
rich in calcium-binding domains, promotes deposition of
calcium in the arterial wall and that calcification is simply a
bystander to aortic stiffening. Only data from future longitu-
dinal or interventional studies will provide greater evidence
of causality. We also assessed total calcification, being
unable to distinguish between medial and intimal calcifica-
tion with CT. Although these are distinct pathological pro-
cesses, both are linked to aortic stiffening in CKD patients16
and are thought to have similar effects on the vessel wall.45
Moreover, although pathological studies may distinguish
between the 2 forms of calcification, they are unable to
provide true measures of in vivo stiffness. Another potential
criticism might be the somewhat subjective assessment of the
calcification in the thoracic aorta. The reasons for this
approach relate to the fact that there are usually relatively few
disjointed flecks of calcification, which makes precise ob-
jective assessment open to error, especially given the
curvature of the ascending and proximal descending aorta,
motion artifacts in the ascending aorta, prominent osteo-
phytes adjacent to the descending aorta, and the variable
extent of calcification at the site of the ligamentum
arteriosum. However, it is reassuring that the subjective
assessments in the thoracic aorta were very much in line
with the objective measurements in the standard 5-cm
length of abdominal aorta, which, being much straighter,
offers reliable31 computer-based measurements. Finally,
we cannot exclude the possibility that long-term antihy-
pertensive therapy modulates arterial calcification, and the
role of calcification in defining the response to antihyper-
tensive medication needs to be further explored in
treatment-naive ISH subjects.
Perspectives
We have demonstrated that aortic calcification is an
independent predictor of aortic stiffness and brachial pulse
pressure in healthy individuals and that ISH is associated
with exaggerated aortic calcification and stiffening. These
data imply that aortic calcification may play an important
role in arterial stiffening and the development of ISH.
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Moreover, the extent of calcium deposition may determine
the response to antihypertensive therapy. This may have
important implications for the rational design of new
therapeutic strategies to treat the large number of older
subjects with ISH.
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